DarshanTalks Podcast
Welcome to DarshanTalks!
We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there!
Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do.
We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career.
DarshanTalks Podcast
Are Pharma Giants Ignoring Clinical Trial Site Issues?
In this episode, Daniel Fox discusses the key challenges faced by research sites, including trust issues, payment delays, and operational setbacks. He emphasizes initiatives like the "Open Mic" policy for anonymous feedback and the grassroots movement Save Our Sites (SOS). Dr. Fox also explores issues with decentralized clinical trials, advocates for patient-centric practices, and underscores the roles of telehealth and AI in research, promoting transparency and ethical standards in clinical research operations.
1. What are the key challenges faced by clinical trial sites?
2. How can we ensure that sites have a platform to voice their concerns?
3. What is Save our sites?
4. Why SCOPE and ACRP may not be suitable platforms for sites?
5. How can we address the economics of running a conference when we do need people to buy those slots?
6. What is the incentive for individual sites to speak up?
7. The Decentralized Clinical Trials Controversy and Citizen Petitions
8. The role of Telehealth in Clinical Research
9. Does a DCT eliminate the need for localized PIs?
10. The Future of AI in Clinical Research
Check out Daniel Fox's websites:
CRPN- crpn.crpaynet.com
Save Our Sites- www.saveoursites.com
White paper- https://lnkd.in/ek9_NNT7
YouTube: @CRPNCentral
